AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Polyrizon Ltd. Ordinary Shares
XNAS · usd
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG0194GNBX3
8.73▲ 0.00 (0.05%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
Financial Highlights
Revenue (TTM)
—
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
—
Net Debt
Trading Information
Previous Close
8.72
Day's Range
8.73 – 9.37
52-Week Range
0.48 – 18.20
Volume
14.6K
Avg Volume
27.1K
Share Statistics
Shares Outstanding
Employees
1
Exchange
XNAS
Listed
2024-10-29
Share count as of June 30, 2026

Polyrizon Ltd. Ordinary Shares (PLRZ) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Polyrizon Ltd. Ordinary Shares (PLRZ)
What is Polyrizon Ltd. Ordinary Shares's Market Cap?
Polyrizon Ltd. Ordinary Shares's Market Cap is $18.5M, based on as-reported figures from SEC (XBRL) filings.
What is Polyrizon Ltd. Ordinary Shares's Enterprise Value?
Polyrizon Ltd. Ordinary Shares's Enterprise Value is $17.2M, based on as-reported figures from SEC (XBRL) filings.
What is Polyrizon Ltd. Ordinary Shares's EV / EBITDA?
Polyrizon Ltd. Ordinary Shares's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Polyrizon Ltd. Ordinary Shares's Net Income (TTM)?
Polyrizon Ltd. Ordinary Shares's Net Income (TTM) is -$3.3M, based on as-reported figures from SEC (XBRL) filings.
What is Polyrizon Ltd. Ordinary Shares's EBITDA?
Polyrizon Ltd. Ordinary Shares's EBITDA is -$5.6M, based on as-reported figures from SEC (XBRL) filings.
What is Polyrizon Ltd. Ordinary Shares's Diluted EPS (TTM)?
Polyrizon Ltd. Ordinary Shares's Diluted EPS (TTM) is -1.57, based on as-reported figures from SEC (XBRL) filings.
What is Polyrizon Ltd. Ordinary Shares's Net Debt?
Polyrizon Ltd. Ordinary Shares's Net Debt is -$1.3M, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · PLRZAs-filed SEC (XBRL) data
No Quarterly data available for this company — showing Annual instead. This company files annual reports only — foreign private issuers (Form 20-F / 40-F) are not required to file quarterly reports, so no quarterly figures exist to show.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022
Operating expenses:
Research and development expenses
General and administrative expenses
Operating loss
Net loss
Basic net loss per share (in Dollars per share)
Diluted net loss per share (in Dollars per share)